Module 5: Principles of Treatment Session Overview –Aims of TB Treatment –General Principles –Treatment Guidelines.

Slides:



Advertisements
Similar presentations
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Advertisements

Your name Institution/organization Meeting Date. Introduction.
TB Disease and Latent TB Infection
TREATMENT OF TUBERCULOSIS, 2003
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
In The Name of God. Common Adverse Reactions to Anti-TB Drugs.
SESSION 2: Essential Elements of DOT – Part 1. DOT Curriculum Session 22 Risks for Nonadherence When patients are adherent: 1.Risk for developing drug-resistant.
Patient Initial Evaluation & Follow up. Pretreatment screening and evaluation: Initial evaluation serves to establish a baseline and may identify patients.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Treatment of Tuberculosis: New Case Module 7A – March 2010.
1 Constructing a regimen Session 5. USAID TB CARE II PROJECT Principles of designing an MDR-TB treatment regimen Include at least four second-line anti-TB.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Introduction to Tuberculosis
MDR and XDR TB Bruce A. Bush, M.D. Regional Tuberculosis Consultant
Diagnosis of TB.
Tuberculosis (TB) Facts
Double Trouble: Diabetes and Tuberculosis
Clinical Pharmacy.  Tuberculosis is caused by M. tuberculosis, an aerobic, non–spore-forming bacillus that resists decolorization by acid alcohol after.
Unit 5: IPT Isoniazid TB Preventive Therapy
Tuberculosis Infection & Disease: Fundamentals for the General Public
Nurses SOAR! Training Curricula Series
Plans for Diagnosis and Management of Acute Pyelonephritis.
The danger Numero Uno. That’s how it reaches you Unprotected sexual intercourse Intravenous drug abuse and shared needles From a HIV positive mother to.
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
Guidelines for chemotherapy of tuberculosis in Taiwan 馬偕紀念醫院 一般內科及感染科 主治醫師 曾祥洸
Tuberculosis (T.B.) Randy Kim.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
“Don’t tell me TB is under control!” Understanding TB
TUBERCULOSIS * Prevention * Treatment, and * Challenges.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Module 4 Basic Principles of Treatment. “ubo! ubo! ubo!” (cough for 2 weeks or more) Did not take medication medication In Loving Memory of In Loving.
Anri Uys (MSc Pharmacology, BPharm NWU) Medicines Information Centre, Division of Clinical Pharmacology University of Cape Town.
WORK UPS AND MANAGEMENT. Traditional and New Diagnostic Approaches DIAGNOSTICSAPPLICATIONS Traditional approaches - Symptom-based -TST -TB Culture --
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Fundamentals of Tuberculosis. 2 Reported TB Cases United States, Year No. of Cases.
.. Tuberculosis is a chronic infectious and communicable granulomatous disease caused by the Mycobacterium tuberculosis. Tuberculosis most commonly affects.
Core Curriculum Contents Introduction Transmission and Pathogenesis Epidemiology of TB in the U.S. Testing for TB Disease and Infection Diagnosis of TB.
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
Tuberculosis Dr Hafsa Raheel, MBBS, MCPS, FCPS Department of Family and Community Medicine KSU.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Tuberculosis By Fion Kung. Objective  Describe tuberculosis  Describe sigh and symptoms of tuberculosis  Describe the nursing diagnosis for tuberculosis.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
TREATMENT OF TUBERCULOSIS: Prevention: BCG vaccination: It does not prevent infection but limits multiplication and spread of following infection so prevents.
Case Holding (TB-DOTS Training). Case holding a set of procedures which ensures that patients complete their treatment involves assignment of the appropriate.
EPIDEMIOLOGY OF PULMONARY TUBERCULOSIS. LEARNIN G OBJECTIVES State the diagnostic criteria of pulmonary tuberculosis Describe trend & state reasons for.
Tuberculosis. TB is a common infectious disease caused by the bacterium Mycobacterium tuberculosis. The bacteria usually affects the lungs but it can.
The story of Munya* (and us)
Fundamentals of Tuberculosis (TB)
Treatment of TB Disease
Treatment of Latent TB Infection (LTBI)
Tuberculosis (TB) Fundamentals for School Nurses
Epidemiology of pulmonary tuberculosis
بسم الله الرحمن الرحيم.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Tuberculosis in children BY MBBSPPT.COM
Department of Family and Community Medicine KSU
Anti Tuberculosis Norah A A AL KHATHLAN MD 4/18/2019 Failure or MDR_TB.
Presentation transcript:

Module 5: Principles of Treatment Session Overview –Aims of TB Treatment –General Principles –Treatment Guidelines

Learning Objectives Describe 3 basic principles of TB treatment Explain the difference between the 4 treatment categories (Cat I-IV) Understand and describe when and why a regimen may be extended

Aims of TB Treatment Cure the patient of TB Prevent death from active TB or its latent effects Prevent relapse of TB Decrease transmission of TB to others Prevent the development of acquired resistance

Fundamental Responsibility and Approach in TB Treatment Assure that appropriate regimen is prescribed by MOs Ensure successful completion of therapy (adherence) Utilize directly observed therapy (DOT) as standard-of-care

Adherence Nonadherence is a major problem in TB control Patient education is the most effective tool to prevent default—USE IT!! Use case management and directly observed therapy (DOT) to ensure patients complete treatment

Why Do Patients Default? As their condition improves they may feel better and decide they don’t need meds They may experience side effects Forgetfulness/lack of a reminder! Travel to cattle posts without refills Difficulty getting to clinic b/c of work/distance

What is Case Management? Assignment of responsibility within clinic to oversee patient monitoring -bacteriology -DOT -side effects Systematic regular review of patient data Plans in place to address barriers to adherence BEFORE default occurs

Directly Observed Therapy (DOT) Health care worker watches patient swallow each -Dose of medication -Every pill, every day -Self-administered is NOT DOT REMEMBER DOT for all patients on all regimens NO exceptions

DOT in Ghantsi…Can you identify the main elements?

Directly Observed Therapy (DOT) DOT can lead to reductions in relapse and acquired drug resistance Use DOT with other measures to promote adherence DOT is the key to CURE

Treatment of TB Disease

Factors Guiding Treatment Initiation Epidemiologic information –e.g., circulating strains, resistance patterns Clinical, pathological, chest x-ray findings Microscopic examination of acid-fast bacilli (AFB) in sputum smears

Basic Principles of Treatment Determine the patient’s HIV status- this could save their life! Provide safest, most effective therapy in shortest time Multiple drugs to which the organisms are susceptible Never add single drug to failing regimen Ensure adherence to therapy (DOT)

Standard Treatment Regimen Initial phase: standard four drug regimens (INH, RIF, PZA, EMB), for 2 months Continuation phase: additional 4 months

Treatment of TB for HIV-Negative Persons 2 months HRZE followed by 4HR Four drugs in initial regimen always - Isoniazid (INH) - Rifampin (RIF) - Pyrazinamide (PZA) - Ethambutol (EMB) or streptomycin (SM) (Streptomycin replaces Ethambutol in TB meningitis)

Treatment of TB for HIV-Positive Persons Management of HIV-related TB is complex and patient care needs to be coordinated with IDCC HIV-infected patients already on ARVs who develop TB should begin anti-TB meds immediately Patients on 1 st line ARVs may start Category I ATT. Patients on ARV regimen with efavirenz should be reviewed by a specialist. If patient is on 2 nd or 3 rd line ARVs discuss with specialist before starting ATT.

HIV-infected TB patients should be evaluated for ARVs immediately – Pts with CD4<=200 should start ARVs within two weeks after start of ATT – Pts with CD4s>200 may defer until end of ATT Treatment of TB for HIV-Positive Persons

Extrapulmonary TB In most cases, treat with same regimens used for pulmonary TB Bone and Joint TB, Miliary TB, or TB Meningitis in Children Treatment extended > 6 months depending on site of disease In TB meningitis Streptomycin replaces Ethambutol

Children Children are at an increased risk for TB disease If the disease is severe (meningitis, military TB, etc.) use Category I treatment, SM replaces EMB in small children For less severe disease: treat with category III regimen In most cases, treat with same regimens used for adults Infants Treat as soon as diagnosis is suspected Infants and Children

Dosing of CPT in Children Age and weight of child Recommended daily dose Suspension 5ML syrup =200mg/40 mg Child Tablet 100mg/20mg Single strength adult tablet 400mg/80mg Double Strength adult tablet 800mg/160m g 6 weeks to 6 months (<5kg) 100mg sulfamethox asole/20mg trimethoprim2.5ml1 tabletn/a 6 months to 5 years (5- 15Kg) 200mg sulfamethox asole/40mg trimethoprim5ml2 tablets1/2 tabletn/a 6 to post pubertal 400 mg sulfamethox asole/80mg trimethoprim10ml4 tablets1 tablet1/2 tablet Post pubertal and Adults 800 mg sulfamethox asole/160mg trimethoprimn/a 2 tablets1 tablet

Multidrug-Resistant TB (MDR TB) Presents difficult treatment problems Lengthy, multi-drug regimen Side effects common Management complex Treatment must be individualized Clinicians unfamiliar with treatment of MDR TB should seek expert consultation Always use DOT to ensure adherence

Multidrug-Resistant TB (MDR TB) Con’t 6 months intensive treatment (always including an injectable drug) followed by at least an 18 month continuation phase Only specialist physicians at the referral hospitals can initiate MDR treatment

Treatment Monitoring Sputum smear microscopy for AFB at 2 months and 6 months –If positive at two months, repeat at 3 If still smear positive at 3 months, continuation phase (4HR) is still started while awaiting DST results Continue drug-susceptibility tests if smear- positive after 3 months of treatment

Caused byAdverse ReactionSigns and Symptoms Any drugAllergySkin rash EthambutolEye damageBlurred or changed vision Changed color vision Isoniazid, Pyrazinamide or Rifampin HepatitisAbdominal pain Abnormal liver function test results Fatigue Lack of appetite Nausea Vomiting Yellowish skin or eyes Dark urine Adverse Drug Reactions

Caused byAdverse ReactionSigns and Symptoms IsoniazidPeripheral neuropathy Tingling sensation in hands and feet PyrazinamideGastrointestinal intolerance Arthralgia Arthritis Upset stomach, vomiting, lack of appetite Joint aches Gout (rare) StreptomycinEar damage Kidney damage Balance problems Hearing loss Ringing in the ears Abnormal kidney function test results

Caused byAdverse ReactionSigns and Symptoms Rifamycins Rifabutin Rifapentine Rifampin Thrombocytopenia Gastrointestinal intolerance Drug interactions Easy bruising Slow blood clotting Upset stomach Interferes with certain medications, such as birth control pills, birth control implants, and methadone treatment Common Adverse Drug Reactions

Drug Interactions Relatively few drug interactions substantially change concentrations of antituberculosis drugs Antituberculosis drugs sometimes change concentrations of other drugs -Rifamycins can decrease serum concentrations of many drugs, (e.g., most of the HIV-1 protease inhibitors), to subtherapeutic levels -Isoniazid increases concentrations of some drugs (e.g., phenytoin) to toxic levels